The Periodic Paralysis Association (PPA) today announced the 2nd annual World Periodic Paralysis Day (WPPD), to be observed March 23, 2026. The global initiative brings together nonprofit ...

Detailed price information for Wave Life Sci Ord Sh (WVE-Q) from The Globe and Mail including charting and trades.

In 2018, when Nell Choi was 9 years old, she began experiencing symptoms that led to hospitalization and a diagnosis of ...

Sanofi (ENXTPA:SAN) has expanded its rare disease collaboration with Mirecule, focusing on next generation treatments for neuromuscular conditions. The company has deepened its relationship with ...

Dyne Therapeutics (NASDAQ:DYN) executives outlined a slate of 2026 operational and regulatory milestones during a discussion ...

Keros Therapeutics, Inc. KROS is pushing its lead asset, rinvatercept, into neuromuscular disease with Duchenne muscular ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today provided an ...

Kids with Duchenne muscular dystrophy and their families deserve the chance to decide their own future.

Delandistrogene moxeparvovec demonstrated a manageable safety profile across clinical trials for Duchenne muscular dystrophy (DMD), with most adverse events emerging within 90 days of infusion. Barry ...

The ACSM released new resistance training guidelines to improve muscle strength, size, and performance. medical News today ...

Survival in myeloma is clearly being prolonged,” says Mikhael. “Whereas historically, we saw a greater impact in younger ...

Research at Clarkson University is helping people with hypermobile Ehlers-Danlos syndrome (hEDS) move with less pain and more confidence. The study, published in the Journal of Multidisciplinary ...